SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending strongly as the stock breaks into new territory, fueled by news related to China's potential export restrictions on rare earth minerals. The community is bullish, anticipating further gains and a potential short squeeze, while also eyeing long-term prospects tied to deep-sea mining and critical mineral demand. Traders are closely watching for news catalysts and technical formations that could drive the stock higher.

American Battery Technology Co. is a technology company, which engages in the development and marketing of lithium-ion batteries. Its projects include recycling plant, United States Advanced Battery Consortium (USABC), and Tonopah flats. The company was founded on October 6, 2011 and is headquartered in Reno, NV.

American Battery Technology Company

American Battery Technology Company ($ABAT) is trending as traders discuss the potential impact of lithium export controls from China, with some seeing it as a boon for ABAT's energy independence mission. Community members are also anticipating the release of the PFS (Pre-Feasibility Study) and speculating on potential partnerships or government stakes. Bullish sentiment is fueled by the company's position in the battery recycling and lithium production sector.

Global Health Solutions Inc is an American company that works with partners to eliminate diseases that have plagued humanity for centuries and protect the health of populations by helping countries build strong health systems. The private company is located in the US. The company brings together key stakeholders around the world with a common goal to stop diseases and strengthen health systems through powerful partnerships. The company consists of programs and focus areas that cover a range of health issues including neglected tropical diseases, infectious diseases, vaccines, field epidemiology, public health informatics, health workforce development, and health ethics. The company's end goal is to eliminate diseases and protect the health of populations.

Turn Therapeutics Inc.

Turn Therapeutics Inc

Turn Therapeutics ($TTRX) is trending after its recent IPO, with the community discussing its potential for significant gains. Some traders are cautious, pointing to valuation concerns and possible formations on the minute chart, while others see it as the next stock poised for a substantial surge, drawing comparisons to other recent high-flying IPOs.

Serve Robotics, Inc. engages in providing self-driving delivery. It designs, develops, and operates zero-emissions robots that serve people in public spaces, starting with food delivery. The company was founded by Ali Kashani, Dmitry Demeshchuk and MJ Burk Chun in 2017 and is headquartered in Redwood City, CA.

Serve Robotics Inc

Serve Robotics ($SERV) is trending due to a newly announced partnership with DoorDash to expand autonomous sidewalk robot deliveries nationwide, with community members expressing excitement and discussing the potential impact. The multi-year deal builds on Serve's existing operations with Uber Eats, maximizing robot utilization, and investors are betting on the future of last-mile logistics within the robotics sector. Community members are closely watching key technical levels and anticipating further upside.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata Inc. is trending as investors await potential news from the upcoming Gen AI Summit and Q3 earnings report, with community members speculating on possible acquisitions or major contracts. Bullish sentiment is fueled by the recent surge in stock price, institutional buying, and lack of insider selling, while some traders express caution and highlight technical indicators. Discussions also mention potential price targets, fair valuations, and the company's positioning in the AI data market relative to competitors.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending as silver nears a multi-decade high, driven by industrial demand and potential Fed rate cuts, sparking community discussion about a possible breakout. Community members are actively discussing if it will break through the $50 resistance, and some believe a short squeeze is imminent. Some analysts say the stock has more room to run, despite global economic uncertainty.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy. The company was founded by Paul Prager and Nazar Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending due to increasing community discussion around its potential transition into AI infrastructure, drawing comparisons to early NVIDIA. Bullish sentiment is fueled by growing optimism for the Cayuga site approval and anticipation of a short squeeze, given the high short interest and Google's backing. Some investors highlight TeraWulf's advantageous position in the energy sector, which could be critical for AI data centers, while others point to potential delays and dilution concerns.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

Delta Air Lines is trending after reporting strong Q3 earnings, exceeding expectations and raising full-year guidance, boosting investor confidence and lifting the entire airline sector. The community is actively discussing whether to hold or sell, anticipating further gains and a potential rise to new highs. Corporate sales and premium revenue growth reflect strong demand, and the CEO expresses optimism for continued momentum.

Biodexa Pharmaceuticals Plc is a drug delivery technology company. It is focused on the research and development of medicines for rare cancers, via both in-house programs as well as partnered programs. The firm's proprietary platform drug delivery technologies are Q-Sphera platform is a disruptive polymer microsphere technology, which is used for sustained release at the microscale to prolong and control the release of therapeutics over an extended period of time from weeks to months; Midasolve platform is an innovative nano saccharide technology, which is used to dissolve drugs at the nanoscale so that they can be administered in liquid form directly and locally into tumors; Midacore platform is an edge gold nanoparticle technology, which is used for targeting sites of disease at the nanoscale. The company was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

Biodexa Pharmaceuticals Plc - ADR

Biodexa Pharmaceuticals Plc

Biodexa Pharmaceuticals is trending as traders discuss its low float and high borrow fees, drawing comparisons to past volatile runners. The company recently initiated a Phase 2a trial for Type 1 diabetes, adding to existing Phase 3 trial momentum. Some traders cite a recently declared effective $100 million registration statement as a potential risk.

PepsiCo, Inc. engages in the manufacture, marketing, distribution, and sale of beverages, food, and snacks. It operates through the following business segments: Frito-Lay North America (FLNA), Quaker Foods North America (QFNA), PepsiCo Beverages North America (PBNA), Latin America (LatAm), Europe, Africa, Middle East, and South Asia (AMESA), and Asia Pacific, Australia and New Zealand, and China Region (APAC). The FLNA segment consists of branded convenient food businesses in the United States and Canada. The QFNA segment includes cereals, rice, and pasta under the Quaker, Pearl Milling Company, Quaker Chewy, Cap'n Crunch, Life, and Rice-A-Roni brands. The PBNA segment is composed of beverage concentrates, fountain syrups, and finished goods under various beverage brands such as Pepsi, Gatorade, Mountain Dew, Diet Pepsi, Aquafina, Diet Mountain Dew, Sierra Mist, and Mug. The LatAm segment covers beverage, food, and snack businesses in the Latin American region. The Europe segment offers beverage, food, and snack goods in Europe and Sub-Saharan Africa regions. The AMESA segment deals with all beverage and convenient food businesses in Africa, the Middle East, and South Asia. The APAC segment refers to all business operations in the Asia Pacific, Australia and New Zealand, and China region. The company was founded by Donald M. Kendall, Sr. and Herman W. Lay in 1965 and is headquartered in Purchase, NY.

PepsiCo Inc

PepsiCo is trending after reporting earnings that beat expectations, driven by strength in international markets. Community members are discussing the company's focus on cost cuts, innovation, and portfolio reshaping, as well as a new CFO appointment. Some investors believe PepsiCo is undervalued and poised for long-term growth, while others are more cautious, citing volume declines and mixed signals in the Q3 report.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$INMB  
 
&quot;INmune Bio Announces Submission of Phase 2 MINDFuL Trial Results in Alzheimer&#39;s Disease to npj Dementia, a Nature Portfolio Journal&quot; 
 
https://finviz.com/news/178162/inmune-bio-announces-submission-of-phase-2-mindful-trial-results-in-alzheimers-disease-to-npj-dementia-a-nature-portfolio-journal

Ibid

WMarco

Pakalu Papito

Floyd

Isla Moore

Stock screener for investors and traders, financial visualizations.

Finviz

INmune Bio Announces Submission of Phase 2 MINDFuL Trial Results in Alzheimer's Disease to npj Dementia, a Nature Portfolio Journal

StockTwits Web

INmune Bio Inc

  
 
"INmune Bio Announces Submission of Phase 2 MINDFuL Trial Results in Alzheimer's Disease to npj Dementia, a Nature Portfolio Journal" 
 
